Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 24, 2024Advances in TherapyOpen Access

Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study

View Full Paper
Ask AI
Bookmark
Share

Authors

AYAndrés YarurCedars-Sinai Medical CenterGMGerassimos J. MantzarisHellenic Red CrossSWSong WangUniversity of Jinan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yarur et al. (2024) studied this question.

synapsesocial.com/papers/68e6dc34b6db64358765893ahttps://doi.org/10.1007/s12325-024-02825-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Regression Shrinkage and Selection Via the Lasso1996 · 53,106 citations
  2. 2Clinical prognostic factors for disabling Crohn's disease: A systematic review and meta-analysis2013 · 50 citations
  3. 3Vedolizumab as Induction and Maintenance Therapy for Crohnʼs Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy2016 · 186 citations
  4. 4Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients2015 · 186 citations
  5. 5ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment2019 · 1,384 citations